NCT05644392 A Study Evaluating Cadonilimab Injection in Combination With Regorafenib for the Treatment of Biliary Systemic Tumours Status RECRUITING Phase PHASE1
NCT05644379 A Study Evaluating Cadonilimab Injection in Combination With Regorafenib for the Advanced Hepatocellular Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05600309 A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)-China Extension Study Status COMPLETED Phase PHASE3
NCT05524155 Sintilimab Combined With Regorafenib and HAIC in Patients With Colorectal Liver Metastasis Status UNKNOWN Phase PHASE2
NCT05462613 Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal Cancer Status RECRUITING Phase PHASE2/PHASE3
NCT05426811 Regorafenib Plus Raltitrexed as Third-line Treatment in Advanced Colorectal Cancer Patients Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT05425940 Study of XL092 + Atezolizumab vs Regorafenib in Participants With Metastatic Colorectal Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05395741 Regorafenib in Patients With Refractory Primary Bone Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05394740 Clinical Study of Regorafenib and Nivolumab Plus Chemotherapy Status COMPLETED Phase PHASE1/PHASE2
NCT05328908 A Study of Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal Cancer Status TERMINATED Phase PHASE3
NCT05233358 HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or Failure Status UNKNOWN Phase NA
NCT05198934 Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C Mutation Status COMPLETED Phase PHASE3
NCT05194293 Regorafenib and Durvalumab for the Treatment of High-Risk Liver Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05159245 The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs Status RECRUITING Phase PHASE2
NCT05134532 Regorafenib After Progression on Atezolizumab Plus Bevacizumab in Advanced HCC Status UNKNOWN Phase PHASE2
NCT05130021 A Clincal Study of Max-40279-01 in Patients With Advanced Colorectal Cancer Status UNKNOWN Phase PHASE2
NCT05113368 Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer Status RECRUITING Phase PHASE2
NCT05064059 A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007) Status COMPLETED Phase PHASE3
NCT05057052 Cryoablation Combined with Sintilimab Plus Regorafenib in Previously Treated Colorectal Cancer Liver Metastasis Status RECRUITING Phase PHASE2